Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Expert Review of Anti-Infective Therapy is Scopus-indexed (Q1, CiteScore 9.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1478-7210Verify ISSN ↗1744-8336Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 36 / 361 | 90th | Q1 |
| Microbiology (medical) | 20 / 147 | 86th | Q1 |
| Virology | 12 / 86 | 86th | Q1 |
| Microbiology | 34 / 194 | 82nd | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2003–present, best quartile Q1, CiteScore 9.1.
Expert Review of Anti-Infective Therapy is Q1 in Infectious Diseases (rank 36 of 361), Q1 in Microbiology (medical) (rank 20 of 147) and Q1 in Virology (rank 12 of 86), by CiteScore 2025. It is ranked in 4 subject areas in all.
Expert Review of Anti-Infective Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.1, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.024, quartile Q1, with an H-index of 110.
Expert Review of Anti-Infective Therapy is published by Taylor and Francis Ltd. Its print ISSN is 1478-7210 and its online ISSN is 1744-8336.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Expert Review of Anti-Infective Therapy has an h-index of 125 and a 2-year mean of 4.06 citations per paper (OpenAlex). Its Scopus CiteScore is 9.1, quartile Q1. On 2-year citations it ranks #51 of 354 Scopus journals in Infectious Diseases.
Expert Review of Anti-Infective Therapy published 105 papers in 2025; its busiest recent year was 2020 with 205. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (9.5%), Italy (6.7%) and Brazil (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (2.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.